GLOBAL COMPANION DIAGNOSTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Jul 2022 103
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Companion Diagnostics
1.2 Classification of Companion Diagnostics by Type
1.2.1 Overview: Global Companion Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Companion Diagnostics Revenue Market Share by Type in 2021
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Next Generation Sequencing (NGS)
1.3 Global Companion Diagnostics Market by Application
1.3.1 Overview: Global Companion Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Global Companion Diagnostics Market Size & Forecast
1.5 Global Companion Diagnostics Market Size and Forecast by Region
1.5.1 Global Companion Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Companion Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Companion Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Diagnostics Market Drivers
1.6.2 Companion Diagnostics Market Restraints
1.6.3 Companion Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Companion Diagnostics Product and Solutions
2.1.4 Roche Holdings Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Holdings Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Companion Diagnostics Product and Solutions
2.2.4 Abbott Laboratories Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Companion Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Companion Diagnostics Product and Solutions
2.4.4 Agilent Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Life Technologies
2.5.1 Life Technologies Details
2.5.2 Life Technologies Major Business
2.5.3 Life Technologies Companion Diagnostics Product and Solutions
2.5.4 Life Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Life Technologies Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Companion Diagnostics Product and Solutions
2.6.4 GE Healthcare Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Agendia
2.7.1 Agendia Details
2.7.2 Agendia Major Business
2.7.3 Agendia Companion Diagnostics Product and Solutions
2.7.4 Agendia Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Agendia Recent Developments and Future Plans
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business
2.8.3 Qiagen Companion Diagnostics Product and Solutions
2.8.4 Qiagen Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Qiagen Recent Developments and Future Plans
2.9 Genomic Health
2.9.1 Genomic Health Details
2.9.2 Genomic Health Major Business
2.9.3 Genomic Health Companion Diagnostics Product and Solutions
2.9.4 Genomic Health Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Genomic Health Recent Developments and Future Plans
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business
2.10.3 Myriad Genetics Companion Diagnostics Product and Solutions
2.10.4 Myriad Genetics Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Myriad Genetics Recent Developments and Future Plans
2.11 Advanced Cell Diagnostics
2.11.1 Advanced Cell Diagnostics Details
2.11.2 Advanced Cell Diagnostics Major Business
2.11.3 Advanced Cell Diagnostics Companion Diagnostics Product and Solutions
2.11.4 Advanced Cell Diagnostics Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.12 Danaher
2.12.1 Danaher Details
2.12.2 Danaher Major Business
2.12.3 Danaher Companion Diagnostics Product and Solutions
2.12.4 Danaher Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Danaher Recent Developments and Future Plans
2.13 Applied Proteomics
2.13.1 Applied Proteomics Details
2.13.2 Applied Proteomics Major Business
2.13.3 Applied Proteomics Companion Diagnostics Product and Solutions
2.13.4 Applied Proteomics Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Applied Proteomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Companion Diagnostics Players Market Share in 2021
3.2.2 Top 10 Companion Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Companion Diagnostics Players Head Office, Products and Services Provided
3.4 Companion Diagnostics Mergers & Acquisitions
3.5 Companion Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Companion Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Companion Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Companion Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Companion Diagnostics Revenue by Type (2017-2028)
6.2 North America Companion Diagnostics Revenue by Application (2017-2028)
6.3 North America Companion Diagnostics Market Size by Country
6.3.1 North America Companion Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Companion Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Companion Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Companion Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Diagnostics Revenue by Type (2017-2028)
7.2 Europe Companion Diagnostics Revenue by Application (2017-2028)
7.3 Europe Companion Diagnostics Market Size by Country
7.3.1 Europe Companion Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Companion Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Companion Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Companion Diagnostics Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostics Revenue by Region (2017-2028)
8.3.2 China Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Companion Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Companion Diagnostics Revenue by Type (2017-2028)
9.2 South America Companion Diagnostics Revenue by Application (2017-2028)
9.3 South America Companion Diagnostics Market Size by Country
9.3.1 South America Companion Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Companion Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Companion Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Companion Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Companion Diagnostics Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Companion Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Companion Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Companion Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Companion Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Companion Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Companion Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Companion Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Companion Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Roche Holdings Corporate Information, Head Office, and Major Competitors
Table 7. Roche Holdings Major Business
Table 8. Roche Holdings Companion Diagnostics Product and Solutions
Table 9. Roche Holdings Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Companion Diagnostics Product and Solutions
Table 13. Abbott Laboratories Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific Major Business
Table 16. Thermo Fisher Scientific Companion Diagnostics Product and Solutions
Table 17. Thermo Fisher Scientific Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies Companion Diagnostics Product and Solutions
Table 21. Agilent Technologies Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Life Technologies Corporate Information, Head Office, and Major Competitors
Table 23. Life Technologies Major Business
Table 24. Life Technologies Companion Diagnostics Product and Solutions
Table 25. Life Technologies Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare Major Business
Table 28. GE Healthcare Companion Diagnostics Product and Solutions
Table 29. GE Healthcare Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Agendia Corporate Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostics Product and Solutions
Table 33. Agendia Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Qiagen Corporate Information, Head Office, and Major Competitors
Table 35. Qiagen Major Business
Table 36. Qiagen Companion Diagnostics Product and Solutions
Table 37. Qiagen Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 39. Genomic Health Major Business
Table 40. Genomic Health Companion Diagnostics Product and Solutions
Table 41. Genomic Health Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 43. Myriad Genetics Major Business
Table 44. Myriad Genetics Companion Diagnostics Product and Solutions
Table 45. Myriad Genetics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Advanced Cell Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Advanced Cell Diagnostics Major Business
Table 48. Advanced Cell Diagnostics Companion Diagnostics Product and Solutions
Table 49. Advanced Cell Diagnostics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Danaher Corporate Information, Head Office, and Major Competitors
Table 51. Danaher Major Business
Table 52. Danaher Companion Diagnostics Product and Solutions
Table 53. Danaher Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Applied Proteomics Corporate Information, Head Office, and Major Competitors
Table 55. Applied Proteomics Major Business
Table 56. Applied Proteomics Companion Diagnostics Product and Solutions
Table 57. Applied Proteomics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Companion Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Companion Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Companion Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Companion Diagnostics Players Head Office, Products and Services Provided
Table 62. Companion Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Companion Diagnostics New Entrants and Expansion Plans
Table 64. Global Companion Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 65. Global Companion Diagnostics Revenue Share by Type (2017-2022)
Table 66. Global Companion Diagnostics Revenue Forecast by Type (2023-2028)
Table 67. Global Companion Diagnostics Revenue by Application (2017-2022)
Table 68. Global Companion Diagnostics Revenue Forecast by Application (2023-2028)
Table 69. North America Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Companion Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Companion Diagnostics Picture
Figure 2. Global Companion Diagnostics Revenue Market Share by Type in 2021
Figure 3. Polymerase Chain Reaction (PCR)
Figure 4. Immunohistochemistry (IHC)
Figure 5. In Situ Hybridization (ISH)
Figure 6. Next Generation Sequencing (NGS)
Figure 7. Companion Diagnostics Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Laboratories Picture
Figure 11. Other Picture
Figure 12. Global Companion Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Companion Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Companion Diagnostics Revenue Market Share by Region (2017-2028)
Figure 15. Global Companion Diagnostics Revenue Market Share by Region in 2021
Figure 16. North America Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Companion Diagnostics Market Drivers
Figure 22. Companion Diagnostics Market Restraints
Figure 23. Companion Diagnostics Market Trends
Figure 24. Roche Holdings Recent Developments and Future Plans
Figure 25. Abbott Laboratories Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Agilent Technologies Recent Developments and Future Plans
Figure 28. Life Technologies Recent Developments and Future Plans
Figure 29. GE Healthcare Recent Developments and Future Plans
Figure 30. Agendia Recent Developments and Future Plans
Figure 31. Qiagen Recent Developments and Future Plans
Figure 32. Genomic Health Recent Developments and Future Plans
Figure 33. Myriad Genetics Recent Developments and Future Plans
Figure 34. Advanced Cell Diagnostics Recent Developments and Future Plans
Figure 35. Danaher Recent Developments and Future Plans
Figure 36. Applied Proteomics Recent Developments and Future Plans
Figure 37. Global Companion Diagnostics Revenue Share by Players in 2021
Figure 38. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Companion Diagnostics Revenue Market Share in 2021
Figure 40. Global Top 10 Players Companion Diagnostics Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Companion Diagnostics Revenue Share by Type in 2021
Figure 43. Global Companion Diagnostics Market Share Forecast by Type (2023-2028)
Figure 44. Global Companion Diagnostics Revenue Share by Application in 2021
Figure 45. Global Companion Diagnostics Market Share Forecast by Application (2023-2028)
Figure 46. North America Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 47. North America Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 48. North America Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 49. United States Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 53. Europe Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 54. Europe Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 55. Germany Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Companion Diagnostics Revenue Market Share by Region (2017-2028)
Figure 63. China Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 70. South America Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 71. South America Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source

Table of Contents

Related reports :

(Sep 22)

The Capture Software for Healthcare market report provides a detailed analysis of global market size, regional and country-level market size...

(Sep 22)

This report describes the global market size of Hospital Gas from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market...

(Sep 22)

The Healthcare Artificial Intelligence market report provides a detailed analysis of global market size, regional and country-level market s...

(Sep 22)

This report describes the global market size of Homecare Telehealth from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its...

(Aug 22)

The Home Healthcare Software market report provides a detailed analysis of global market size, regional and country-level market size, segme...

(Aug 22)

The Telehealth market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market...

Global Info Research

GLOBAL COMPANION DIAGNOSTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy